35 filings
8-K
FDMT
4D Molecular Therapeutics Inc
24 May 24
Submission of Matters to a Vote of Security Holders
4:28pm
8-K
FDMT
4D Molecular Therapeutics Inc
9 May 24
4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
4:22pm
8-K
FDMT
4D Molecular Therapeutics Inc
29 Feb 24
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
4:12pm
8-K
FDMT
4D Molecular Therapeutics Inc
9 Feb 24
Other Events
4:56pm
8-K
FDMT
4D Molecular Therapeutics Inc
4 Jan 24
Departure of Directors or Certain Officers
8:30am
8-K
qj8x535p
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
tvpsuzt2aidwu 4zyi
9 Nov 23
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
4:23pm
8-K
txd446 o2o6y
12 Sep 23
Departure of Directors or Certain Officers
9:17pm
8-K
6ea8n
9 Aug 23
4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results
4:26pm
8-K
ozhr3euo62idvv0d1
10 Jul 23
Entry into a Material Definitive Agreement
9:31pm
8-K
ha5 8timx
25 May 23
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
sd9e3cli9 ox
10 May 23
4D Molecular Therapeutics Reports First Quarter 2023 Financial Results
6:08pm
8-K
qty330m
9 May 23
Other Events
4:43pm
8-K
4t71n e3i
15 Mar 23
4D Molecular Therapeutics Reports Full Year 2022 Financial Results
4:15pm
8-K
w01rom1c0dh0fwp
2 Feb 23
Other Events
7:08pm
8-K
9b4dpv
26 Jan 23
Other Events
4:50pm
8-K
uwoum1ls1j8 dill1
9 Nov 22
4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
4:08pm
8-K
miusvz8y3lyvld2si2zh
27 Sep 22
Departure of Directors or Certain Officers
4:25pm
8-K
0m0 uxmkr79cwvu253
11 Aug 22
4D Molecular Therapeutics Reports Second Quarter 2022 Financial Results and Provides 4D-310 Program Update
4:19pm
8-K
sdlqfizvi98m2a
17 Jun 22
Amendments to Articles of Incorporation or Bylaws
7:52pm